Genomic features of rapid versus late relapse in triple negative breast cancer
Yiqing Zhang(Zhoukou Normal University), Daniel G. Stover(Harvard University), Samilia Obeng‐Gyasi(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Robert Wesolowski(The Ohio State University Wexner Medical Center), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University), David Tallman(The Ohio State University), Ding Ma(Fudan University Shanghai Cancer Center), Nicole Williams(The Ohio State University), Leming Shi(Fudan University), Zachary Weber(The Ohio State University), Nancy U. Lin(Dana-Farber Cancer Institute), Jerome F. Bey(The Ohio State University), Sinclair Stockard(The Ohio State University), Steven T. Sizemore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jeffrey VanDeusen(The Ohio State University), Sagar Sardesai(The Ohio State University Wexner Medical Center), Bhuvaneswari Ramaswamy(The Ohio State University), Kristin L. Dean(The Ohio State University), Eric P. Winer(University of Vermont), Mathew Cherian(The Ohio State University Wexner Medical Center), Jasneet Singh(The Ohio State University), Maryam B. Lustberg(Yale Cancer Center), Zhi-Ming Shao(Fudan University Shanghai Cancer Center), Claire F. Verschraegen(The Ohio State University), Sarah Asad(The Ohio State University), Meghan Wyse(Comprehensive Cardiovascular), Peng Wang(Chinese Academy of Sciences), Wei Huang(Chinese National Human Genome Center), William Nock(The Ohio State University), Elizabeth J. Adams(The Ohio State University), Gina M. Sizemore(The Ohio State University)
Cited by 28
Related Papers
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
|Cancer Discovery|2019|1.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k